Laura Philips reports a stock award at Niki BioSolutions

By AlphaYouPublished Oct 21, 2026Form 4

Stocks in this disclosure

Reported activity

Philips Laura A

Reporting filer

Laura Philips reports a stock award, not an open-market purchase or sale, in Niki BioSolutions, Inc.. Form 4 filed Oct 21, 2026 lists 1 entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock Options (derivative)	Philips Laura A	2026-07-22	A	Grant or award	8000	0	8,000	91 days	Filed terms security Title: Stock Options conversion Or Exercise Price: 8.83 transaction Date: 2026-07-22 deemed Execution Date: transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Timeliness: transaction Shares: 8000 transaction Price Per Share: 0 transaction Acquired Disposed Code: A id: F1 expiration Date: 2036-07-22 underlying Security Title: Common Stock underlying Security Shares: 8000 shares Owned Following Transaction: 8000 direct Or Indirect Ownership: D

Owner: Philips Laura A
Date: 2026-07-22
Code: A
Action: Grant or award
Quantity: 8000
Price: 0
Following holdings: 8,000
Reporting delay: 91 days
Filed terms and references: Filed terms
security Title: Stock Options
conversion Or Exercise Price: 8.83
transaction Date: 2026-07-22
deemed Execution Date:
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 8000
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-07-22
underlying Security Title: Common Stock
underlying Security Shares: 8000
shares Owned Following Transaction: 8000
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Philips Laura A: Director.
F1: The options vest as follows: (i) 2,000 options vested immediately upon the closing of the merger; and (ii) the remaining 6,000 options vest in three equal quarterly installments of 2,000 options each, commencing on the first business day of the first full quarter following the effective date of the merger.

Prepared automatically from public filing data. Report a correction.